EU agency recommends extended approval of Roche's Actemra

04/26/2010 | Reuters

Roche Holding said the European Medicines Agency recommended extended approval of Actemra, an anti-interleukin-6 receptor antibody, for use in combination with standard treatment methotrexate in patients with rheumatoid arthritis. The company received the recommendation after providing the EU agency with two years of clinical data.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN